Evidence map›Paper›PMID 25414699›Full record

ReviewFrontiers in immunology2014

In silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem-Cell Transplant Donors and Recipients: Understanding the Quantitative Immunobiology of Allogeneic Transplantation.

Max Jameson-Lee, Vishal Koparde, Phil Griffith, Allison F Scalora, Juliana K Sampson, Haniya Khalid, Nihar U Sheth, Michael Batalo, Myrna G Serrano, Catherine H Roberts and 5 more

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2015
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2019
    Article
  7. Article
  8. Article
  9. The Graft-Versus-Leukemia Effect in AML.Frontiers in oncology · 2019
    Review
  10. Article
  11. Review
  12. Frontiers in immunology · 2018
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Max Jameson-LeeStem Cell Transplant Program, Massey Cancer Center, Virginia Commonwealth University , Richmond, VA , USA.
Vishal KopardeThe Center for the Study of Biological Complexity, Virginia Commonwealth University , Richmond, VA , USA.
Phil GriffithStem Cell Transplant Program, Massey Cancer Center, Virginia Commonwealth University , Richmond, VA , USA.
Allison F ScaloraStem Cell Transplant Program, Massey Cancer Center, Virginia Commonwealth University , Richmond, VA , USA.
Juliana K SampsonThe Center for the Study of Biological Complexity, Virginia Commonwealth University , Richmond, VA , USA.
Haniya KhalidStem Cell Transplant Program, Massey Cancer Center, Virginia Commonwealth University , Richmond, VA , USA.
Nihar U ShethThe Center for the Study of Biological Complexity, Virginia Commonwealth University , Richmond, VA , USA.
Michael BataloStem Cell Transplant Program, Massey Cancer Center, Virginia Commonwealth University , Richmond, VA , USA.
Myrna G SerranoThe Center for the Study of Biological Complexity, Virginia Commonwealth University , Richmond, VA , USA.
Catherine H RobertsStem Cell Transplant Program, Massey Cancer Center, Virginia Commonwealth University , Richmond, VA , USA.
Michael L HessDepartment of Internal Medicine, Virginia Commonwealth University , Richmond, VA , USA.
Gregory A BuckThe Center for the Study of Biological Complexity, Virginia Commonwealth University , Richmond, VA , USA.
Michael C NealeDepartment of Psychiatry and Statistical Genomics, Virginia Commonwealth University , Richmond, VA , USA.
Masoud H ManjiliDepartment of Microbiology and Immunology, Virginia Commonwealth University , Richmond, VA , USA.
Amir Ahmed ToorStem Cell Transplant Program, Massey Cancer Center, Virginia Commonwealth University , Richmond, VA , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Donor T-cell mediated graft versus host (GVH) effects may result from the aggregate alloreactivity to minor histocompatibility antigens (mHA) presented by the human leukocyte antigen (HLA) molecules in each donor-recipient pair undergoing stem-cell transplantation (SCT). Whole exome sequencing has previously demonstrated a large number of non-synonymous single nucleotide polymorphisms (SNP) present in HLA-matched recipients of SCT donors (GVH direction). The nucleotide sequence flanking each of these SNPs was obtained and the amino acid sequence determined. All the possible nonameric peptides incorporating the variant amino acid resulting from these SNPs were interrogated in silico for their likelihood to be presented by the HLA class I molecules using the Immune Epitope Database stabilized matrix method (SMM) and NetMHCpan algorithms. The SMM algorithm predicted that a median of 18,396 peptides weakly bound HLA class I molecules in individual SCT recipients, and 2,254 peptides displayed strong binding. A similar library of presented peptides was identified when the data were interrogated using the NetMHCpan algorithm. The bioinformatic algorithm presented here demonstrates that there may be a high level of mHA variation in HLA-matched individuals, constituting a HLA-specific alloreactivity potential.

Indexed as

alloreactivity potentialHLAminor histocompatibility antigenstem-cell transplantwhole exome sequencing

Identifiers

PMID25414699
PMCPMC4222229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.